Jay R. Campbell
Director/Board Member at Update Pharma, Inc.
Profile
Jay R.
Campbell is currently a Director at Update Pharma, Inc. He previously worked as a Senior Development-Business Development at Kolltan Pharmaceuticals, Inc. and as a Chief Business Officer & VP-Investor Relations at Immutep Ltd.
He completed his undergraduate degree at Bucknell University.
Jay R. Campbell active positions
Companies | Position | Start |
---|---|---|
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Director/Board Member | - |
Former positions of Jay R. Campbell
Companies | Position | End |
---|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Corporate Officer/Principal | - |
IMMUTEP LIMITED | Investor Relations Contact | - |
Training of Jay R. Campbell
Bucknell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IMMUTEP LIMITED | Health Technology |
Private companies | 2 |
---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Distribution Services |
- Stock Market
- Insiders
- Jay R. Campbell